Cargando…

Management and outcomes of patients with Crohn’s disease with first vs multiple surgeries: results from the PRACTICROHN study

BACKGROUND: Surgery in Crohn’s disease (CD) may be associated with poor prognosis and clinical and surgical recurrence. The aim of this study was to describe and compare the post-operative management and outcomes of patients with CD who underwent first vs recurrent surgeries. METHODS: Observational...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iborra, Marisa, Juliá, Berta, Martín Arranz, Maria Dolores, Barreiro-de Acosta, Manuel, Gutiérrez, Ana, García-Sánchez, Valle, Taxonera, Carlos, Gisbert, Javier P, Cea-Calvo, Luis, Domènech, Eugeni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081962/ https://www.ncbi.nlm.nih.gov/pubmed/32211194 http://dx.doi.org/10.1093/gastro/goz029

Ejemplares similares

Perioperative management and early complications after intestinal resection with ileocolonic anastomosis in Crohn’s disease: analysis from the PRACTICROHN study
por: Gutiérrez, Ana, et al.
Publicado: (2019)

Response to Infliximab in Crohn's Disease: Genetic Analysis Supporting Expression Profile
por: Medrano, Luz María, et al.
Publicado: (2015)

Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity
por: Guijarro, Luis G., et al.
Publicado: (2022)

Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease
por: Chaparro, María, et al.
Publicado: (2019)

Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial
por: Chaparro, María, et al.
Publicado: (2019)

The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn’s Disease
por: Iborra, Marisa, et al.
Publicado: (2022)

Inflammatory bowel disease integral care units: Evaluation of a nationwide quality certification programme. The GETECCU experience
por: Barreiro‐de Acosta, Manuel, et al.
Publicado: (2021)

Optimizing post-operative Crohn’s disease treatment
por: Domènech, Eugeni, et al.
Publicado: (2014)

Epidemiological, Clinical, Patient-Reported and Economic Burden of Inflammatory Bowel Disease (Ulcerative colitis and Crohn’s disease) in Spain: A Systematic Review
por: Barreiro-de Acosta, Manuel, et al.
Publicado: (2023)

Editorial: Postoperative management of Crohn's disease: One size does not fit all
por: Domènech, Eugeni, et al.
Publicado: (2023)

Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis
por: Cañete, Fiorella, et al.
Publicado: (2020)

Recurrent granulomatous cheilitis associated with Crohn’s disease successfully treated with ustekinumab: case report and literature review
por: Taxonera, Carlos, et al.
Publicado: (2020)

Possible Biomarkers in Blood for Crohn's Disease: Oxidative Stress and MicroRNAs—Current Evidences and Further Aspects to Unravel
por: Moret-Tatay, Inés, et al.
Publicado: (2016)

Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications
por: Moret-Tatay, Inés, et al.
Publicado: (2021)

Identification of Epigenetic Methylation Signatures With Clinical Value in Crohn's Disease
por: Moret-Tatay, Inés, et al.
Publicado: (2019)

Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn’s Disease
por: Gisbert, Javier P., et al.
Publicado: (2023)

Oxidative Stress in the Pathogenesis of Crohn’s Disease and the Interconnection with Immunological Response, Microbiota, External Environmental Factors, and Epigenetics
por: Alemany-Cosme, Ester, et al.
Publicado: (2021)

Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohorts
por: Fernández-Gutiérrez, Benjamín, et al.
Publicado: (2017)

Real-World Evidence of the Effectiveness and Safety of Ustekinumab for the Treatment of Crohn’s Disease: Systematic Review and Meta-Analysis of Observational Studies
por: Rubín de Célix, Cristina, et al.
Publicado: (2022)

Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial
por: Howaldt, Stefanie, et al.
Publicado: (2021)

Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn’s Disease Patients: The SUSTAIN Study
por: Chaparro, María, et al.
Publicado: (2022)

Randomised clinical trial: intravenous vs oral iron for the treatment of anaemia after acute gastrointestinal bleeding
por: Ferrer‐Barceló, Luis, et al.
Publicado: (2019)

Serum adipokines as non-invasive biomarkers in Crohn’s disease
por: Ortega Moreno, Lorena, et al.
Publicado: (2020)

Corrigendum to: Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial
por: Howaldt, Stefanie, et al.
Publicado: (2021)

Prácticas de cultivo in vitro y transformación genética de plantas
por: Gisbert Doménech, Carmina
Publicado: (2008)

Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
por: Chaparro, María, et al.
Publicado: (2022)

State of the Art in LP-WAN Solutions for Industrial IoT Services
por: Sanchez-Iborra, Ramon, et al.
Publicado: (2016)

Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease on Biological Agents During the SARS-CoV-2 Pandemic
por: Iborra, Ignacio, et al.
Publicado: (2021)

Development of a Prediction Model for Short-Term Remission of Patients with Crohn’s Disease Treated with Anti-TNF Drugs
por: Medina-Medina, Rosario, et al.
Publicado: (2023)

IFNγ-Treated Macrophages Induce EMT through the WNT Pathway: Relevance in Crohn’s Disease
por: Macias-Ceja, Dulce C., et al.
Publicado: (2022)

Empirical vs. Susceptibility-Guided Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis
por: Nyssen, Olga P., et al.
Publicado: (2022)

Diminished Vitamin D Receptor Protein Levels in Crohn’s Disease Fibroblasts: Effects of Vitamin D
por: Gisbert-Ferrándiz, Laura, et al.
Publicado: (2020)

Adipose-Derived Stem Cells in Crohn's Rectovaginal Fistula
por: García-Olmo, D., et al.
Publicado: (2010)

Appropriateness of routine pre-endoscopic SARS-CoV-2 screening with RT-PCR in asymptomatic individuals and its impact on delayed diagnosis
por: Fortuny, Marta, et al.
Publicado: (2023)

Appropriateness of routine pre-endoscopic SARS-CoV-2 screening with RT-PCR in asymptomatic individuals and its impact on delayed diagnosis
por: Fortuny, Marta, et al.
Publicado: (2023)

Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU
por: Riestra, Sabino, et al.
Publicado: (2022)

Mechanisms of Microbe–Host Interaction in Crohn’s Disease: Dysbiosis vs. Pathobiont Selection
por: Buttó, Ludovica F., et al.
Publicado: (2015)

Evaluation of changes in intestinal microbiota in Crohn’s disease patients after anti-TNF alpha treatment
por: Sanchis-Artero, Laura, et al.
Publicado: (2021)

Patients’ perceptions of the impact of ulcerative colitis on social and professional life: results from the UC-LIFE survey of outpatient clinics in Spain
por: Calvet, Xavier, et al.
Publicado: (2018)

Preferences and satisfaction of IBD patients after switching from adalimumab 40 mg weekly to 80 mg every other week given as a single injection: the ADASCAL study
por: Taxonera, Carlos, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6tpo3acddpiol0p7n3b2k1fu7m